Cargando…

Generation of Affinity Purified Antibody Reagents for Specific Determination of Efruxifermin in Biological Matrices

Efruxifermin (EFX) is a novel Fc-fusion analog of human fibroblast growth factor 21 (FGF21), currently in clinical development as a potential treatment for non-alcoholic steatohepatitis (NASH). Each molecule of EFX consists of two modified FGF21 molecules, each attached at their N-termini to a human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinne, Adam S, Abdeen, Sanofar J, Parmer, Elijah S, Thystrup, Jennifer A, Tillman, Erik J, Rolph, Timothy P, Bowsher, Ronald R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Cardiovascular Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266200/ http://dx.doi.org/10.1210/jendso/bvab048.585

Ejemplares similares

ODP178 Development and Validation of a Noncompetitive Immunoassay Optimized for the Assessment of Pharmacokinetics of Biologically Active Efruxifermin in Humans
por: Hurst, Jacob, et al.
Publicado: (2022)

Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain
por: Johnson, Derrick, et al.
Publicado: (2021)

Efruxifermin, a long‐acting Fc‐fusion FGF21 analogue, reduces body weight gain but does not increase sympathetic tone or urine volume in Sprague Dawley rats
por: Tillman, Erik J., et al.
Publicado: (2022)

A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis
por: Harrison, Stephen A., et al.
Publicado: (2022)

FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
por: Tillman, Erik J., et al.
Publicado: (2020)

Affimer proteins are versatile and renewable affinity reagents
por: Tiede, Christian, et al.
Publicado: (2017)

FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein
por: Miller, Christina J., et al.
Publicado: (2021)

An overview of enzymatic reagents for the removal of affinity tags
por: Waugh, David S.
Publicado: (2011)

Mitochondria-associated regulation in adipose tissues and potential reagents for obesity intervention
por: Zheng, Yali, et al.
Publicado: (2023)

Streamlining the Pipeline for Generation of Recombinant Affinity Reagents by Integrating the Affinity Maturation Step
por: Huang, Renhua, et al.
Publicado: (2015)

Translation of ceragenin affinity for bacteria to an imaging reagent for infection
por: Bandara, Nilantha, et al.
Publicado: (2019)

Reversible protein affinity-labelling using bromomaleimide-based reagents
por: Nathani, Ramiz I., et al.
Publicado: (2013)

Low Affinity GPCRs for Metabolic Intermediates: Challenges for Pharmacologists
por: Smith, Nicola J.
Publicado: (2012)

SUN-059 Uvular Angioedema
por: Varghese, Ron, et al.
Publicado: (2019)

Ferromagnetic Levan Composite: An Affinity Matrix to Purify Lectin
por: Angeli, Renata, et al.
Publicado: (2009)

PSUN68 Finerenone for Primary Aldosteronism: A Novel Mineralocorticoid Receptor Antagonist
por: Aurora, John, et al.
Publicado: (2022)

Recent developments of novel matrices and on-tissue chemical derivatization reagents for MALDI-MSI
por: Zhou, Qiuqin, et al.
Publicado: (2020)

OR17-01 Leptin Decreases De Novo Lipogenesis in Lipodystrophic Patients
por: Baykal, Annah Petek, et al.
Publicado: (2020)

Protein-Protein Interactions of Tandem Affinity Purified Protein Kinases from Rice
por: Rohila, Jai S., et al.
Publicado: (2009)

Analysing Point Mutations in Protein Cleavage Sites by Using Enzyme Specificity Matrices
por: Triebel, Jakob, et al.
Publicado: (2019)

PCSK9 Inhibitors for the Management of Mitotane-Induced Hypercholesterolemia in Adrenocortical Carcinoma
por: Aurora, John A, et al.
Publicado: (2021)

Influence of Target Concentration and Background Binding on In Vitro Selection of Affinity Reagents
por: Wang, Jinpeng, et al.
Publicado: (2012)

Introducing the Affinity Binder Knockdown Initiative⿿A public⿿private partnership for validation of affinity reagents
por: Alm, Tove, et al.
Publicado: (2016)

Exact S-matrices for nonsimply-laced affine Toda theories
por: Delius, G.W., et al.
Publicado: (1992)

Genome-Wide Meta-Analysis and Mendelian Randomization Identify Early Biomarkers of Non-Alcoholic Fatty Liver Disease
por: Gobeil, Emilie, et al.
Publicado: (2021)

ODP146 Exploring Systemic Inflammation in the Relationships Between Poor Sleep Health or Shift-Work and Blood Pressure Across BMI, Sex and Age Groups
por: Young, Morag, et al.
Publicado: (2022)

OR02-1 Differences in HDL Particle Composition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Liver Fibrosis May Explain Higher Cardiovascular Risk
por: Collier, Timothy, et al.
Publicado: (2022)

OR04-2 Aldosterone Induces Trained Immunity via Fatty Acid Synthesis
por: van der Heijden, Charlotte, et al.
Publicado: (2019)

FRI092 Rationale And Design Of The Balance Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Of Olezarsen In Patients With Familial Chylomicronemia Syndrome
por: Alexander, Veronica, et al.
Publicado: (2023)

THU585 Non-alcoholic Fatty Liver Disease (NAFLD), A Silent But Emerging Problem In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry
por: Henry, Scott M., et al.
Publicado: (2017)

A Recombinant Affinity Reagent Specific for a Phosphoepitope of Akt1
por: McGinnis, Jennifer E., et al.
Publicado: (2018)

Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications
por: Gonzalez-Sapienza, Gualberto, et al.
Publicado: (2017)

Global lysine methylome profiling using systematically characterized affinity reagents
por: Berryhill, Christine A., et al.
Publicado: (2023)

Branched Multimeric Peptides as Affinity Reagents for the Detection of α-Klotho Protein
por: Ye, Xiyun, et al.
Publicado: (2023)

Highly efficient in vitro translation of authentic affinity-purified messenger ribonucleoprotein complexes
por: Fritz, Sarah E., et al.
Publicado: (2018)

SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA
por: Kahn, Steven, et al.
Publicado: (2019)

Matrices and Affinity Ligands for Antibody Purification and Corresponding Applications in Radiotherapy
por: Xue, Aiying, et al.
Publicado: (2022)

The Relationship Between the Aldosterone-to-Renin Ratio and Blood Pressure in Young Adults: A Longitudinal Study
por: Yang, Jun, et al.
Publicado: (2021)

Dimerization Capacities of FGF2 Purified with or without Heparin-Affinity Chromatography
por: Platonova, Natalia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v550214dutqlp7lopji5p3db6a